Tech Company Financing Transactions
Chroma Therapeutics Funding Round
On 12/7/2004, Chroma Therapeutics raised $10 million in funding from EW Healthcare Partners.
Transaction Overview
Company Name
Announced On
12/7/2004
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
EW Healthcare Partners (Lead Investor) (Petri Vainio)
Proceeds Purpose
The new funds will enable Chroma to further accelerate the development of its existing pipeline of small molecule oncology drugs targeted against chromatin-modifying enzymes, and to rapidly progress drug discovery activities against an emerging class of chromatin-modifying enzymes to ensure it remains at the forefront of research in the chromatin field.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
93 Milton Park
Oxon, OX14 4RY
UK
Oxon, OX14 4RY
UK
Phone
Website
Email Address
Overview
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Peter Allen
Chief Executive Officer
Richard Bungay
Chief Medical Officer
Martin Toal
Browse more venture capital transactions:
Prev: 12/6/2004: Jigsaw Data venture capital transaction
Next: 12/7/2004: Kollective venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs